Category: Third Age

Kapa3 Introduces Its New Psychological Support Team

On the occasion of May, Mental Health Awareness Month, and June, a month dedicated to cancer survivors, Kapa3 introduces its new Psychological Support Team.

The experience of cancer does not affect only the body. It deeply touches a person’s emotional world, daily life, relationships, family, work and sense of safety. From the moment of diagnosis, throughout treatment, and also in life after treatment, patients and their loved ones are often called to cope with fear, uncertainty, change, loss, exhaustion and, at times, a profound sense of loneliness.

At Kapa3, we know that supporting people affected by cancer requires a holistic approach. Information about rights, benefits and procedures is essential. Guidance through the health and social care system is equally important. But people also need a safe space where they can speak, be heard, express what weighs on them and receive support with respect, discretion and professionalism.

Kapa3’s new Psychological Support Team has been created for this purpose: to provide counselling and psychosocial support to people experiencing cancer, as well as to caregivers and family members.

The aim of the service is to empower, support and improve the quality of life of beneficiaries. Through psychological support, individuals may better recognise what they are experiencing, manage anxiety and uncertainty, strengthen their emotional resilience and feel that they are not alone in their journey.

The service is addressed to adult cancer patients, survivors, caregivers and family members. Support may relate to different stages of the cancer experience, including a new diagnosis, active treatment, the post-treatment period, recurrence, long-term follow-up or the daily challenges faced by caregivers.

Support is provided through a cycle of up to eight individual sessions, scheduled in consultation with the beneficiary and according to the availability of the service. Sessions may take place either in person or online, depending on the needs of the beneficiary and the operational framework of the service.

Confidentiality, professional ethics and the protection of personal data are central to the service. Participation is based on informed consent, and the information shared by the beneficiary remains confidential. Any exchange of information between Kapa3’s Psychological and Social Services is limited strictly to what is necessary in order to provide appropriate support.

The new team is part of Kapa3’s broader philosophy of interdisciplinary, person-centred and responsible care. Psychological support is connected with social guidance, information on rights and benefits, referral needs and the overall empowerment of the beneficiary.

At the same time, the service operates within clear boundaries. It has a supportive and counselling character and does not replace psychiatric monitoring, emergency psychiatric intervention or long-term psychotherapy. When needed, beneficiaries may be guided towards appropriate services or specialised mental health professionals.

At Kapa3, we believe that no one should have to face cancer alone. Psychological support is not a luxury. It is part of care. It is a space for listening, acceptance and empowerment.

Asking for help is not a weakness.
It is an act of care.
It is an act of self-awareness.
It is an act of strength.

Kapa3 – Cancer Guidance Centre
Together, with knowledge, care and human presence.

Co-Creating Myrto: A Digital Health and Rights Navigator for Cancer Patients

After five years of continuous work supporting cancer patients through digital guidance, the Cancer Guidance Center – Kapa3 is developing a new pioneering project: Myrto.

Myrto is a Social Artificial Intelligence intervention in the field of welfare and cancer patient support in Greece. It is an advanced digital tool, integrated into Kapa3’s website, designed to function as a digital health and rights navigator — a Patient Empowerment e-Navigator for people experiencing cancer, their caregivers and the professionals who support them.

Myrto is not limited to simply providing information. Its purpose is to interact, guide and evolve through the real needs of users. With particular attention to accessibility, the psychological dimension of the cancer experience and the everyday reality of patients, Myrto aims to become a human-centred and trustworthy environment for information, empowerment and support.

At Kapa3, we know that the cancer experience is not limited to diagnosis or treatment. It is often accompanied by uncertainty, administrative procedures, the search for rights, the need for social benefits, psychosocial pressure, practical barriers and the need for reliable guidance. For this reason, Myrto is being designed to support people throughout this complex journey in a clear, accessible and understandable way.

The development of Myrto is based on collaboration and co-creation. Recognising the multifaceted work of organisations, professionals and institutions that work daily with vulnerable groups, Kapa3 is inviting partners to contribute to the pilot testing, evaluation and improvement of the tool.

The experience of field professionals is invaluable. Social workers, legal experts, psychologists, healthcare professionals, social care organisations and civil society actors who work closely with people affected by cancer can make a meaningful contribution by identifying the most frequent questions, needs and concerns that emerge in everyday practice.

In this context, Myrto will be developed, tested and evaluated with the contribution of relevant experts, so that it responds to the real needs of cancer patients, caregivers and the professionals who support them. The evaluation will take place both online and in person in different parts of Greece, strengthening participation, accessibility and representativeness.

For Kapa3, technology has value when it serves people. Myrto is not being developed as an isolated technological product, but as part of a broader digital, inclusive and human-centred support framework. Its aim is to strengthen access to information, help patients and families understand available options and rights, and support the work of professionals who stand beside them at every stage of the journey.

The success of the project depends on collaboration. Together with organisations, professionals and communities, we are designing a tool that does not begin with technology, but with people’s real needs.

Myrto is a step towards more accessible, human-centred and equal support for cancer patients. A step that brings together field experience, social care, digital innovation and active participation.

Because real innovation in health and welfare is not only about creating new tools. It is about creating them together with those who understand the real needs.

Palliative Care in Cancer: Ensuring Quality of Life Alongside Treatment

Palliative Care in Cancer: Ensuring Quality of Life Alongside Treatment

The editorial underlines the vital role of palliative care in cancer management. While advances in oncology have improved survival, many patients still face significant physical, emotional, and social challenges. Palliative care focuses on relieving symptoms such as pain, fatigue, and anxiety, while also supporting families and caregivers.

Research shows that early integration of palliative care improves patients’ quality of life, helps them tolerate demanding treatments, and even extends survival in some cases. It also facilitates better communication between patients and healthcare providers and reduces unnecessary hospitalizations and costs.

Despite this evidence, palliative care remains underused, often mistaken for end-of-life care only. In Greece, until recently it was not formally part of the National Health System, and existing services remain limited. However, the 2022 legal framework and the position paper of the Hellenic Society of Medical Oncology stress the urgent need for wider integration, more training for oncologists, and stronger policy support.

Ultimately, oncology success should not be measured only in survival rates but also in ensuring dignity, comfort, and holistic support for patients throughout their journey.

Read more care

Consumer wearables could make ‘positive contribution to routine care’

Consumer wearables that measure heart rate and physical activity provide similar clinical value to standard hospital tests for atrial fibrillation (AF) and heart failure, new research has found.

The study, published in Nature Medicine, examined whether a commercially-available fitness tracker and smartphone could continuously monitor the response to medications, and provide clinical information similar to in-person hospital assessment.

The wearable devices, consisting of a wrist band and connected smartphone, collected a vast amount of data on the response to two different medications prescribed as part of a clinical trial called RATE-AF, funded by the National Institute for Health and Care Research (NIHR).

Researchers used artificial intelligence (AI) to help analyse over 140 million datapoints for heart rate in 53 individuals over 20 weeks.

They found that digoxin and beta-blockers had a similar effect on heart rate, even after accounting for differences in physical activity.

This was in contrast to previous studies that had only assessed the short-term impact of digoxin.

A neural network that took account of missing information was developed to avoid an over-optimistic view of the wearable data stream.

Using this approach, the team found that the wearables were equivalent to standard tests often used in hospitals and clinical trials that require staff time and resources.

The average age of participants in the study was 76 years, highlighting possible future value regardless of age or experience with technology.

Professor Dipak Kotecha from the Institute of Cardiovascular Sciences at the University of Birmingham and the lead author of the study said: “People across the world are increasingly using wearable devices in their daily lives to help monitor their activity and health status.

“This study shows the potential to use this new technology to assess the response to treatment and make a positive contribution to the routine care of patients.”

“Heart conditions such as atrial fibrillation and heart failure are expected to double in prevalence over the next few decades, leading to a large burden on patients as well as substantial healthcare cost.

“This study is an exciting showcase for how artificial intelligence can support new ways to help treat patients better.”

https://www.htworld.co.uk/news/wearables/consumer-wearables-could-make-positive-contribution-to-routine-care/

 

Cancer is on the rise in under-50s – a key task is to work out why

Nine in 10 of all cancers affect people over 50 but research shows a worrying rise in early onset cases

There are many upsides to growing old, but one of the downsides, unfortunately, is a higher risk of developing cancer. Increasing age is a key risk factor. And with more of us living longer worldwide, millions of older people will have to contend with the disease

Now a new study adds weight to previous work warning of a grim trend in global health: cancer in people under the age of 50 is becoming more common.

In the study, researchers led by the University of Edinburgh in Scotland and Zhejiang University School of Medicine in Hangzhou, China, found that the number of under-50s being diagnosed with cancer worldwide rose by 79% between 1990 and 2019, from 1.82 million to 3.26 million. Cancer deaths in the same age group grew by 27%, and more than 1 million under-50s a year are now dying of cancer, the research published in BMJ Oncology reveals

The study is not the first to show the trend. A review in 2022 of cancer registry records from 44 countries found that the incidence of early onset cancer was rising rapidly for 14 types of cancers, and this increase was happening across many middle- and high-income nations.

The new research adds meat to the bone. Examining data from 204 countries, it found a striking increase in the global incidence of early onset cancers. It also showed the highest incidence rates of cancer in the under-50s was in North America, Oceania and western Europe.

Researchers worldwide are only just starting their next task: working out why.

The authors of the 2022 review, led by Harvard University, said any uptick in testing or checks could not account for the rise in diagnoses. They suggested the rise was most likely due to an unhealthy mix of risk factors that could be working together, some which are known and others of which need to be investigated.

Many of these risks had established links to cancer such as obesity, inactivity, diabetes, alcohol, smoking, environmental pollution and western diets high in red meat and added sugars, not to mention shift work and lack of sleep. Experts have speculated that ultra-processed food may also be partly to blame

The researchers behind the new study echoed those observations. Genetic factors are likely to have a role, they say. But diets high in red meat and salt and low in fruit and milk, as well as alcohol consumption and tobacco use, are the main risk factors underlying the most common cancers among under-50s, with physical inactivity, excess weight and high blood sugar other contributory factors.

As worrying as the increase in early onset cancers is, caution is required. Cancer in people under 50 is still uncommon. With breast cancer, the most common type in under-50s, there were 13.7 cases per 100,000 people in 2019. Nine in 10 of all cancers affect people over 50.

Until experts unlock definitive answers, there remains plenty that people young and old can do to reduce their risk of cancer. Not smoking, maintaining a balanced diet and a healthy weight, getting plenty of exercise and staying safe in the sun are among them.

 

Andrew GregoryHealth editor

https://www.theguardian.com/science/2023/sep/05/cancer-is-on-the-rise-in-under-50s-a-key-task-is-to-work-out-why?utm_source=salesforce-marketing-cloud&utm_medium=email&utm_campaign=September+12+2023+Cancer+Today+E-newsletter&utm_term=Read+More+in+the+Guardian

Depression Is Often Overlooked in Cancer Patients

When Carly Flumer was a teenager, she was diagnosed with anxiety and depression. She saw a psychiatrist and a therapist regularly, and got medication and counseling. She managed her mental health well for over a decade. But in January 2017, she was diagnosed with an aggressive form of thyroid cancer that had spread to her lymph nodes by the time it was diagnosed.

That’s when things got complicated again.

Flumer, then 27, underwent surgery to remove her thyroid. She also received intensive radiation. To all observers, she got a clean bill of health — at least with regard to her cancer. But, she says, her mental health had suffered.

“People absolutely do not understand the panic a cancer diagnosis can cause,” Flumer says. “My depression and anxiety got worse when I got diagnosed. I also have had more suicidal thoughts because of the cancer,” she says. “The side effects of treatment are real. So is the stress of waiting to see if the cancer comes back again.”

The Economics of Health for All and the Transformative Power of the Arts

In the first-ever report of its kind, the WHO Council on the Economics of Health for All has outlined a bold new path to reorient economies to deliver what matters – health for all.

The Council has put forward a bold new narrative grounded in new economic wisdom to reorient economies to deliver health for all across four interrelated themes:

  1. Value – valuing and measuring what matters through new economic metrics;
  2. Finance – how to finance health for all as a long-term investment, not a short-term cost;
  3. Innovation – how to advance health innovation for the common good;
  4. Capacity – how to strengthen dynamic public sector capacity to achieve health for all.

Meet the new WHO Goodwill Ambassadors for Arts and Health

The appointments of Fleming and Yende underscore the profound link between arts and health. Engagement in creative activities, such as music, art, and dance, positively impacts physical, mental health, social well-being, and overall quality of life.

Through their roles as Goodwill Ambassadors, Fleming and Yende will promote the integration of arts into healthcare systems, advocate for access to creative arts therapies, and champion the importance of artistic expression in improving health outcomes globally.

Health for All Film Festival

A shortlist of 93 films has been selected for the 4th Health for All Film Festival out of more than 780 entries received.

Watch the shortlisted films here. Winners will be announced on 6 June.

Key highlights from the Seventy-sixth World Health Assembly

As the world faces ongoing health and humanitarian emergencies, the Seventy-sixth World Health Assembly focuses on driving forward health for all. This year’s session of the World Health Assembly determines the immediate and longer-term future of WHO, starting with the program budget for the next two years, key decisions about the sustainable financing of the Organization and changes put in place to improve WHO’s processes and accountability. Delegates also deliberate about the critical role that WHO has in the Global Health Emergency Architecture.
Read more :

World Health Organization